Immatics at the CAR-TCR Summit 2018 (Sept 4-7) in Boston, MA

| News, USA

Immatics is part of the CAR-TCR Summit 2018 in Boston (Sept 4-7)! Join our experts and have interesting discussions.

 

September 4th, 12:00pm-2:00pm

Workshop I: "Manufacturing of TCR Based T Cells for Solid Tumors: Experience and Lessons Learned

Chair: Ali Mohamed (Vice President CMC, Immatics US)

 

September 5th

11:15am-11:45am

"Multivalent TCR-T Therapy Using Novel Targets"

Speaker: Steffen Walter (CSO, Immatics US)

Session: "CAR-TCR Discovery"

 

5:15pm-5:45pm

Plenary Session: "How to make CAR/TCR Therapies work beyond the CD19/ALL Paradigm?"

Chair: Steffen Walter (CSO, Immatics US)

 

September 6th, 8:00am-9:15am

Poster 1: "Manufacturing of TCR-engineered T cells in 5-6 days

Poster 2: "The ACTolog® Approach: Multi-target Adoptive Cell Therapy using Endogenous Antigen Specific T cells

Presenter: Geoffrey Stephens (Director Product Science, Immatics US), Steffen Walter (CSO, Immatics US)

 

September 7th, 8:45am-3:30pm

Focus Day: "Overcoming CAR-T Toxicity in Solid Tumors

Chair: Ali Mohamed (Vice President CMC, Immatics US)

 

Further information on CAR-TCR Summit here.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back